| Authors: |
Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic. Electronic address: pour.ludek@fnbrno.cz., Delimpasi S; Department of Haematology, Evangelismos Hospital, Athens, Greece., Legiec W; Department of Hematology and Bone Marrow Transplantation, St. John of Dukla Oncology Center, and Institute of Medical Science, Faculty of Medicine, The John Paul II Catholic University of Lublin, Poland., Minarik J; Department of Hemato-Oncology, University Hospital Olomouc, Olomouc, Czech Republic., Spicka I; First Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic., Grosicki S; Department of Cancer Prevention, Medical University of Silesia, Katowice, Poland., Rymko M; Department of Bone Marrow Transplantation and Hematologic Oncology, Nasz Lekarz Medical Outpatient Clinics Slawomir Jeka, Toruń, Poland., Najda J; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland., Symeonidis A; Department of Internal Medicine, University of Patras, Patras, Greece., Andersson B; Oncopeptides AB, Stockholm, Sweden., Huledal G; Oncopeptides AB, Stockholm, Sweden., Norin S; Oncopeptides AB, Stockholm, Sweden., Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece; Department of Medicine, Korea University, Seoul, South Korea. |
